Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association study of -1727 A/T, -50 C/T and (CAA)n repeat GSK-3beta gene polymorphisms with schizophrenia.

Neuropsychobiology - 1 Jan 2004

Scassellati Catia, Bonvicini Cristian, Perez Jorge, Bocchio-Chiavetto Luisella, Tura Gian Battista, Rossi Giuseppe, Racagni Giorgio, Gennarelli Massimo

Abstract excerpt

Glycogen synthase kinase-3 (GSK-3) is a downstream component of the Wnt pathway and recent studies have reported abnormal levels of GSK-3beta in schizophrenia. In a sample of 147 schizophrenic patients and 212 healthy individuals, we analyzed two common SNPs at position -1727 A/T and -50 C/T and a (CAA)(n) repeat polymorphism localized in intron 1 of the gene. The results showed that the allele, genotype and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Glycogen Synthase Kinase 3

Share to Glycogen Synthase Kinase 3 beta

Share to Polymorphism, Genetic

Share to Schizophrenia

Share to Trinucleotide Repeats

Source

Identifiers

PMID: 15179015
DOI: 10.1159/000077936

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association study of -1727 A/T, -50 C/T and (CAA)n repeat GSK-3beta gene polymorphisms with schizophrenia.PMID 15179015Read ↗

No significant association between the genetic polymorphisms in the GSK-3 beta gene and schizophrenia in the Chinese population.Semantic proximity Read ↗

No association of two common SNPs at position -1727 A/T, -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population.Semantic proximity Read ↗

Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder.Semantic proximity Read ↗

GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.Semantic proximity Read ↗

Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response.Semantic proximity Read ↗

The GSK3B gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population.Semantic proximity Read ↗

No association of GSK3beta gene (GSK3B) with Japanese schizophrenia.Semantic proximity Read ↗

Genetic association and identification of a functional SNP at GSK3β for schizophrenia susceptibility.Semantic proximity Read ↗

Beta-catenin in schizophrenia: Possibly deleterious novel mutation.Semantic proximity Read ↗

Increase in GSK3beta gene copy number variation in bipolar disorder.Semantic proximity Read ↗

Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity.Semantic proximity Read ↗

Association of GSK-3β genetic variation with GSK-3β expression, prefrontal cortical thickness, prefrontal physiology, and schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.